Innoviva
INVA
246 hedge funds and large institutions have $1.23B invested in Innoviva in 2025 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 81 increasing their positions, 90 reducing their positions, and 24 closing their positions.
58% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 24
5% more funds holding
Funds holding: 235 → 246 (+11)
1% less capital invested
Capital invested by funds: $1.24B → $1.23B (-$8.89M)
2% less call options, than puts
Call options by funds: $44K | Put options by funds: $45K
5.66% less ownership
Funds ownership: 113.6% → 107.95% (-5.7%)
10% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 90
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$22.9M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$8.74M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.31M |
| 4 |
Two Sigma Investments
New York
|
+$7.26M |
| 5 |
Two Sigma Advisers
New York
|
+$6.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$80M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$39.7M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$8.29M |
| 4 |
Goldman Sachs
New York
|
-$6.93M |
| 5 |
BlackRock
New York
|
-$5.55M |
INVA Hedge Fund Activity: Q1 2025 in Review
246 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2025, worth a combined $1.23B — down 0.72% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new INVA positions and 24 closed out — a net gain of 14 holders — while 81 added to existing stakes and 90 trimmed.
The largest buyer was Millennium Management, adding an estimated $22.9M. The largest seller was Sarissa Capital Management, cutting an estimated $80M.
- 246 institutional investors held Innoviva (INVA) as of Q1 2025, up from 235 in Q4 2024.
- Funds reported $1.23B of Innoviva stock for Q1 2025, down 0.72% quarter-over-quarter.
- 38 funds opened new Innoviva positions in Q1 2025 and 24 closed out, a net change of +14 holders.
- The largest Innoviva buyer in Q1 2025 was Millennium Management, an estimated $22.9M added.
- The largest Innoviva seller in Q1 2025 was Sarissa Capital Management, an estimated $80M sold.
Based on aggregated 13F filings for Q1 2025.